A detailed history of Cribstone Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 7,558 shares of ABBV stock, worth $1.34 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
7,558
Previous 8,064 6.27%
Holding current value
$1.34 Million
Previous $1.08 Million 12.94%
% of portfolio
0.72%
Previous 0.67%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $69,984 - $83,930
-506 Reduced 6.27%
7,558 $1.22 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $19,863 - $22,781
-148 Reduced 1.8%
8,064 $1.08 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $2,339 - $2,974
-17 Reduced 0.21%
8,212 $1.26 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $130,396 - $161,785
-988 Reduced 10.72%
8,229 $1.33 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $7,627 - $9,651
71 Added 0.78%
9,217 $1.25 Million
Q3 2021

Nov 18, 2021

BUY
$106.4 - $120.78 $151,407 - $171,869
1,423 Added 18.43%
9,146 $987,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $23,882 - $26,606
227 Added 3.03%
7,723 $870,000
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $290,327 - $319,615
2,838 Added 60.93%
7,496 $811,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $82,904 - $111,930
1,030 Added 28.39%
4,658 $499,000
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $257 - $302
-3 Reduced 0.08%
3,628 $318,000
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $252,466 - $337,837
3,441 Added 1811.05%
3,631 $356,000
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $19,350 - $29,337
-300 Reduced 61.22%
190 $14,000
Q4 2019

Jan 08, 2020

SELL
$72.13 - $90.25 $134,666 - $168,496
-1,867 Reduced 79.21%
490 $43,000
Q3 2019

Nov 20, 2019

SELL
$62.98 - $75.72 $87,983 - $105,780
-1,397 Reduced 37.21%
2,357 $178,000
Q2 2019

Jul 22, 2019

SELL
$65.7 - $83.98 $8,212 - $10,497
-125 Reduced 3.22%
3,754 $273,000
Q1 2019

Apr 11, 2019

SELL
$77.14 - $90.79 $7,636 - $8,988
-99 Reduced 2.49%
3,879 $313,000
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $6,461 - $7,968
-83 Reduced 2.04%
3,978 $367,000
Q3 2018

Oct 25, 2018

BUY
$88.91 - $98.84 $6,134 - $6,819
69 Added 1.73%
4,061 $384,000
Q1 2018

Apr 19, 2018

BUY
$92.01 - $123.21 $64,407 - $86,247
700 Added 21.26%
3,992 $378,000
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $13,523 - $14,829
-151 Reduced 4.39%
3,292 $318,000
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $240,493 - $307,184
3,443
3,443 $306,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cribstone Capital Management, LLC Portfolio

Follow Cribstone Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.